South Dakota Investment Council Has $385,000 Stake in Lantheus Holdings Inc (NASDAQ:LNTH)

South Dakota Investment Council decreased its position in shares of Lantheus Holdings Inc (NASDAQ:LNTH) by 39.0% in the second quarter, Holdings Channel reports. The fund owned 13,600 shares of the medical equipment provider’s stock after selling 8,700 shares during the period. South Dakota Investment Council’s holdings in Lantheus were worth $385,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in the business. Mason Street Advisors LLC lifted its position in Lantheus by 3.6% during the 1st quarter. Mason Street Advisors LLC now owns 12,380 shares of the medical equipment provider’s stock worth $303,000 after acquiring an additional 435 shares during the last quarter. State Board of Administration of Florida Retirement System lifted its position in Lantheus by 5.3% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 12,522 shares of the medical equipment provider’s stock worth $354,000 after acquiring an additional 630 shares during the last quarter. Arizona State Retirement System lifted its position in Lantheus by 1.3% during the 2nd quarter. Arizona State Retirement System now owns 60,218 shares of the medical equipment provider’s stock worth $1,704,000 after acquiring an additional 752 shares during the last quarter. TD Asset Management Inc. lifted its position in Lantheus by 1.4% during the 2nd quarter. TD Asset Management Inc. now owns 63,009 shares of the medical equipment provider’s stock worth $1,783,000 after acquiring an additional 900 shares during the last quarter. Finally, Texas Permanent School Fund lifted its position in Lantheus by 4.0% during the 1st quarter. Texas Permanent School Fund now owns 26,173 shares of the medical equipment provider’s stock worth $641,000 after acquiring an additional 1,002 shares during the last quarter. 95.73% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts have weighed in on LNTH shares. CJS Securities raised shares of Lantheus from a “market perform” rating to an “outperform” rating in a research report on Friday, August 16th. Zacks Investment Research lowered shares of Lantheus from a “hold” rating to a “sell” rating in a research report on Friday, August 2nd. ValuEngine lowered shares of Lantheus from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, BidaskClub raised shares of Lantheus from a “hold” rating to a “buy” rating in a research report on Friday. One research analyst has rated the stock with a sell rating, one has issued a hold rating and two have assigned a buy rating to the company. Lantheus has an average rating of “Hold” and an average price target of $29.00.

In related news, SVP Michael P. Duffy sold 8,819 shares of the company’s stock in a transaction dated Wednesday, July 10th. The shares were sold at an average price of $28.14, for a total value of $248,166.66. Following the sale, the senior vice president now owns 144,494 shares of the company’s stock, valued at $4,066,061.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Brian A. Markison sold 5,000 shares of the company’s stock in a transaction dated Wednesday, June 19th. The shares were sold at an average price of $27.40, for a total transaction of $137,000.00. Following the completion of the sale, the director now directly owns 42,467 shares in the company, valued at approximately $1,163,595.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 111,552 shares of company stock worth $2,911,266. Insiders own 2.60% of the company’s stock.

Shares of NASDAQ:LNTH traded up $0.55 on Friday, hitting $24.58. 7,699 shares of the company were exchanged, compared to its average volume of 275,368. The company’s 50 day moving average price is $22.62 and its two-hundred day moving average price is $24.74. Lantheus Holdings Inc has a one year low of $12.59 and a one year high of $29.80. The company has a debt-to-equity ratio of 2.05, a quick ratio of 2.01 and a current ratio of 2.62. The firm has a market capitalization of $869.96 million, a price-to-earnings ratio of 26.20, a PEG ratio of 1.87 and a beta of 1.50.

Lantheus (NASDAQ:LNTH) last posted its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $0.27 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.27. Lantheus had a net margin of 11.20% and a return on equity of 51.08%. The company had revenue of $85.70 million for the quarter, compared to the consensus estimate of $88.72 million. During the same quarter in the previous year, the firm posted $0.25 EPS. The business’s revenue was up .1% compared to the same quarter last year. Research analysts predict that Lantheus Holdings Inc will post 1 earnings per share for the current year.

Lantheus Profile

Lantheus Holdings, Inc develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide. Its principal products include DEFINITY, a microbubble contrast agent used in ultrasound exams of the heart; and TechneLite, a technetium generator that provides the nuclear material used in nuclear medicine procedures.

Recommended Story: Front-End Load

Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings Inc (NASDAQ:LNTH).

Institutional Ownership by Quarter for Lantheus (NASDAQ:LNTH)

Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit